Changes in peritoneal mesothelial cells phenotype after chronic exposure to glucose or N-acetylglucosamine

Translational Research

Volumn 150, Issue 6, 2007, Pages 337-342

  Ciszewicz, Maria ^a   Wu, George ^b   Tam, Paul ^b   Polubinska, Alicja ^a   Brȩborowicz, Andrzej ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b Institute of Kidney Lifescience Technologies   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; FIBRONECTIN; GLUCOSE; HYALURONIC ACID; INTERLEUKIN 6; N ACETYLGLUCOSAMINE; PLASMINOGEN ACTIVATOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; REACTIVE OXYGEN METABOLITE; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN;

ANALYTIC METHOD; ARTICLE; CELL CULTURE; CELL HYPERPLASIA; CELL POPULATION; CELL PROLIFERATION; COMPARATIVE STUDY; CONTROLLED STUDY; CULTURE MEDIUM; FIBRINOLYSIS; HUMAN; HUMAN CELL; MESOTHELIUM CELL; OXIDATIVE STRESS; PERITONEUM CELL; PHENOTYPE; PRIORITY JOURNAL;

EID: 36049023809     PISSN: 19315244     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trsl.2007.07.002     Document Type: Article

References (22)

1. Naiki Y., Maeda Y., Matsuo K., et al. Involvement of TGF-β signal for peritoneal sclerosis in continuous ambulatory peritoneal dialysis. J Nephrol 16 (2003) 95-102
2. Lee H.B., Yu M.R., Song J.S., and Ha H. Reactive oxygen species amplify protein kinase C signaling in high glucose-induced fibronectin expression by human peritoneal mesothelial cells. Kidney Int 65 (2004) 1170-1179
3. Ksia{ogonek}żek K., Brȩborowicz A., Jorres A., and Witowski J. Oxidative stress contributes to accelerated development of the senescent phenotype in human peritoneal mesothelial cells exposed to high glucose. Free Radic Biol Med 42 (2007) 636-641
4. Margetts P.J., Bonniaud P., Liu L., et al. Transient overexpression of TGF-{beta}1 induces epithelial mesenchymal transition in the rodent peritoneum. J Am Soc Nephrol 16 (2005) 425-436
5. Witowski J., Wisniewska J., Korybalska K., et al. Prolonged exposure to glucose degradation products impairs viability and function of human peritoneal mesothelial cells. J Am Soc Nephrol 12 (2001) 2434-2441
6. Witowski J., Korybalska K., Ksia{ogonek}żek K., et al. Peritoneal dialysis with solutions low in glucose degradation products is associated with improved biocompatibility profile towards peritoneal mesothelial cells. Nephrol Dial Transplant 19 (2004) 917-924
7. Williams J.D., Topley N., Craig K.J., et al. The Euro-Balance Trial: the effect of a new biocompatible peritoneal dialysis fluid (balance) on the peritoneal membrane. Kidney Int 66 (2004) 408-418
8. Brȩborowicz A., Kul̂an-Pawlaczyk M., Wieczorowska-Tobis K., et al. The effect of N-Acetylglucosamine as a substrate for in vitro synthesis of glycosaminoglycans by human peritoneal mesothelial cells and fibroblasts. Adv Perit Dial 14 (1998) 31-35
9. Brȩborowicz A., Pawlaczyk-Kuzlan M., Pawlaczyk K., Baum E., Tam P., and Wu G. Replacement of glucose with N-acetylglucosamine in peritoneal dialysis fluid-experimental study in rats. Perit Dial Int 21 suppl 3 (2001) s316-s318
10. Zawalich W.S., Dye E.S., and Matschinsky F.M. Metabolism and insulin releasing capabilities of glucosamine and N-acetylglucosamine in isolated rat islets. Biochem J 180 (1979) 145-152
11. Ha H., Yu M.R., and Lee H.B. High glucose-induced PKC activation mediates TGF-beta 1 and fibronectin synthesis by peritoneal mesothelial cells. Kidney Int 59 (2001) 463-470
12. Gotloib L., Shostak A., Wajsbrot V., and Kushnier R. High glucose induces a hypertrophic, senescent mesothelial cell phenotype after long in vivo exposure. Nephron 82 (1999) 164-173
13. Breborowicz A., Rodela H., and Oreopoulos D.G. Toxicity of osmotic solutes on human mesothelial cells in vitro. Kidney Int 41 (1992) 1280-1285
14. Ksiazek K., Piwocka K., Brzezinska A., et al. Early loss of proliferative potential of human peritoneal mesothelial cells in culture: the role of p16INK4a-mediated premature senescence. J Appl Physiol 100 (2006) 988-995
15. Shostak A., Wajsbrot V., and Gotloib L. High glucose accelerates the life cycle of the in vivo exposed mesothelium. Kidney Int 58 (2000) 2044-2052
16. Fujimori A., Naito H., Miyazaki T., et al. Elevation of interleukin 6 in the dialysate reflects peritoneal stimuli and deterioration of peritoneal function. Nephron 74 (1996) 471-472
17. Breborowicz A., Wisniewska J., Moberly J.B., and Oreopoulos D.G. L-2-oxothiazolidine-4-carboxylic acid modulates function of peritoneal mesothelial cells in vitro. Am J Kidney Dis 34 (1999) 663-668
18. Shikhman A.R., Kuhn K., Alaaeddine N., and Lotz M. N-acetylglucosamine prevents IL-1β-mediated activation of human chondrocytes. J Immunol 166 (2001) 5155-5160
19. Połubinska A., Pawlaczyk K., Kuẑlan-Pawlaczyk M., et al. Dialysis solution containing hyaluronan: effect on peritoneal permeability and inflammation in rats. Kidney Int 57 (2000) 1182-1189
20. diZerega G.S., and Campeau J.D. Peritoneal repair and post-surgical adhesion formation. Hum Reprod Update 7 (2001) 547-555
21. Levin R.M., Krieger N.N., and Winzler R.J. Glucosamine and acetylglucosamine tolerance in man. J Lab Clin Med 58 (1961) 927-932
22. Lee K.Y., Shibutani M., Takagi H., et al. Subchronic toxicity study of dietary N-acetylglucosamine in F344 rats. Food Chem Toxicol 42 (2004) 687-695